ABT vs PODD
Abbott Laboratories (ABT) and Insulet (PODD) compared side by side. Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $10.3B for Insulet, about 17.4 times the size. On trailing earnings, PODD is cheaper at 27.9x versus 38.6x for ABT.
Head to head
| Metric | ABT | PODD |
|---|---|---|
| Market cap | $179.4B | $10.3B |
| P/E (TTM) | 38.6x | 27.9x |
| Forward P/E | 17.4x | 19.3x |
| Revenue (TTM) | $48.2B | $3.1B |
| Revenue growth | 14.5% | 23.5% |
| Gross margin | 57.1% | 71.1% |
| Operating margin | 11.3% | 16.2% |
| Free cash flow | $7.4B | $265.6M |
| Dividend yield | 2.43% | None |
| 1-year return | -15.9% | -53.9% |
| 5-year return (annual) | -2.0% | -13.3% |
| Max drawdown | -46% | -90% |
| FI Handbook grade | C+ | B- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
ABT vs PODD FAQ
Which is bigger, ABT or PODD?
Abbott Laboratories (ABT) is larger, with a market cap of $179.4B versus $10.3B for Insulet, about 17.4 times the size.
Is ABT or PODD cheaper?
On trailing earnings, PODD is cheaper at 27.9x versus 38.6x for ABT. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, ABT or PODD?
ABT returned -15.9% over the past year including dividends, versus -53.9% for PODD, through October 23, 2026.
Which pays a higher dividend, ABT or PODD?
ABT yields 2.43%; PODD does not pay a dividend.
Full pages: Abbott Laboratories · Insulet